SUMMARY An external quality assessment scheme (EQAS) in the technical aspects of histopathology is described, and the results obtained over a two-year period assessed. The scheme involved 42 laboratories of varied work load, and the slides returned by the laboratories, both haematoxylin and eosin and special stains. were marked by panels of four assessors. The reliability of assessment was checked by comparing the results of two separate panels of assessors, and by asking the same panel to assess the same set of slides on a different occasion. The participants' evaluation of the scheme was tested by questionnaire.
External technical quality assessment poses many more problems in histopathology than in other branches of pathology, largely because the assessment is subjective rather than numerate. It has been shown previously that external quality assesstnent (EQA) is applicable to histopathology in a small scheme in a restricted area.' We now report results obtained from a much larger trial of EQA over a two-year period. We hoped in this trial to determine: (a) English histopathology laboratories were categorised as having low, medium or high work loads (<4000, 4000-8000, and >8000 requests per annum). One laboratory was chosen at random from each of these categories from each of 14 regional health authorities and invitations to participate were sent to the chief medical laboratory scientific officer (MLSO) and consultant pathologist in each department.
Accepted for publication 10 June 1982 Thirty-eight of the 42 departments invited accepted the invitations, two declined and two did not reply. Four reserve departments accepted their invitations, so completing the required number for the trial. Participation was voluntary and confidential. MATERIAL 
CIRCULATED
For 20 months, each department was sent a fixed block of tissue monthly except for one month when serial sections were sent. The blocks for any month were taken from the same specimen and were as closely similar as possible. The departments were asked to treat the assessment block in the same way as their routine surgical biopsy specimens. They were asked to return stained slides, usually both a haematoxylin and eosin (H and E) and a special staining technique, to the organisers by a specified date. The time allowed was not more than three weeks. The specimens and stains requested are shown in Tables 1 and 2. ASSESSMENT Each slide was marked by four assessors. During the first year of the scheme the slides were sent to a second (control) panel of four assessors, to enable comparison of the consistency of assessment to be carried out.
Because of the numbers involved, the laboratories Tables 1 and 2 .
Annual reports to the participants gave a general analysis of each year's performance and showed th'e department's half-yearly mean scores, the means and ranges for the group and the number of slides received which were considered less than adequate (less than 8 marks). Each laboratory was informed of its position in the rank order of laboratories for each of the four half-yearly periods.
FEEDBACK
During the second year of the scheme the participating MLSOs and pathologists were asked to complete questionnaires. In addition to a common general section, the MLSOs were asked to complete a technical section. Barr (b) A regression analysis was carried out on the scores given for each slide by the primary and by the control assessors. The first year's slides were analysed in eight groups each containing 89-95 slides. For each of the eight groups the correlation was found to be highly significant (Table 4) .
Re-assessment One panel of assessors was asked to repeat the assessment on one group of slides from the first year, adopting both the old and the new methods for the H and E slides.
Of the H and E slides, 62% were given the same individual mark, no slide was more than one mark away from the original score. In 88% of the H and E slides and in 75% of the special slides the total mark given was the same or within one mark of the original total assessment (range 4-16 marks). In all, 33 slides were reassessed by the same panel of assessors, regression analysis showed a highly significant correlation between the original and the repeat assessments (r = 0*729; p<0*001). 
Comparison of assessment by MLSOs and pathologists
Over the two years the mean assessment of all slides by MLSOs was 10-56 whilst that of pathologists was 10*30.
LABORATORY PERFORMANCE
The total number of marks given by a panel of assessors to an individual section ranged from 4 to 16, although the extremes were infrequent. If the relatively small number of slides not returned is ignored, the mean mark given to each laboratory over a halfyear period ranged from 7.2 to 12*6. 11*9% of slides were given assessments of less than 8, and were therefore considered less than adequate. While laboratory performance varied considerably from circulation to circulation, there was reasonable consistency in the overall assessment of laboratory Table 5 . An analysis of the most commonly requested staining techniques was made in order to ensure that these had been or would be included in the scheme. Each laboratory was asked to list its 10 most commonly performed special stains. The overall "top ten" are shown in Table 6 in order of frequency. All Most of the general comments on the scheme were favourable. There were a few specific objections to the scheme but the majority of the adverse comments related to requests for more detailed reasons from the assessors to explain low marks.
Discussion
The major criticisms of EQA schemes in histopathology are that they are unnecessary, unworkable, and inaccurate. The major difference between histopathology and other pathology disciplines lies in the subjective nature of the assessment, and one of the major purposes of this investigation was to test whether assessment of the technical aspects of a section could be reliable. We have shown that when assessors were asked to mark slides on their acceptability for diagnosis, there was a considerable difference in the marking standards applied by different assessors. This was true both when the assessors were asked to consider the preparation as a whole, and when they were asked to mark staining separately from earlier procedures. The differences were not surprising, but they were considerable, and must be taken into account in the application of any such scheme. We have also found, however, a high degree of consistency in the standards applied by assessors, both in their performance relative to one another, and in the reproducibility of individual assessments when repeated on the same slides over a year later. This suggests that the relative standard of preparation can be assessed with acceptable accuracy, but that in this pilot scheme, for changes in the marks given to any one'laboratory over a period of time to be meaningful, the same assessors and the same marking system should be used. We believe that this difficulty could be largely overcome in any future scheme by including in each batch marked by the assessors a group of slides from a previous assessment of the same stain carried out on the same tissue, and comparing the two sets of marks. This would only be possible in an EQA scheme that ran for a number of years, but we believe it would allow assessment of absolute as well as relative change in a laboratory's performance.
The marking scale we adopted has proved easy to apply, although arguments could be put forward for expanding or contracting it. To mark a slide only as acceptable or not acceptable would simplify marking still further, but we believe that the inability to recognise the outstanding slide, as well as the lack of separation between a good and a just adequate preparation would be a considerable loss, and would not help to maintain high standards in the laboratory. The demand from the participating laboratories was, as shown by the questionnaire, for more, not less, detailed marking.
One common criticism of histopathology EQA schemes is that the material returned has been specially treated, and is therefore not representative of the laboratories' routine output. All of the replies to the questionnaire stated that the test material was treated as routine; all laboratories used automatic processors. A minority, while claiming to treat them as routine, did in fact ensure that all staff in the department in turn performed the microtomy on the test blocks. In the majority of departments H and E staining was carried out automatically, both for routine and test sections; in only one department were the test special stains always carried out by one selected member of staff.
The evidence therefore suggests that in the great majority of instances the test material was not specially treated. Even if a much greater proportion were specially treated we do not believe that this would invalidate the scheme, as one of the most valuable uses of a scheme such as this is to provide an independent yardstick against which a department can measure its own standards. The responsibility for maintaining standards rests on a department, and the general standard in the UK is, we believe, high. In all departments who replied to the questionnaire, the results were discussed with the technical staff concerned, and in the great majority of the departments, with the pathologist also.
As well as providing an objective standard against which a department can measure its technical attainment, this scheme has a number of other benefits. It asks the laboratories to perform a wide range of special stains and provides them with a wide range of material which may not always be available to them otherwise. It provides information which can help to determine whether differences in performance of certain stains is due to batch variation, and it provides a sense of participation at a national level that may be particularly iniportant to small or isolated laboratories.
In the United Kingdom national EQA schemes operate for all major pathology disciplines, except histopathology; the operation of these schemes has recently been reviewed2 and a Welsh EQA scheme in histopathology, previously described' has now been running successfully for five years. Internationally we know of schemes in development or in progress in the USA, Australia and Ireland. A World Health Organisation working group has recently dis-cussed the whole background of EQA schemes and recommends their extension.3
In the United Kingdom we believe that a nationwide scheme for histopathology, organised only from one centre, would pose considerable logistic problems, both because of the difficulties of providing uniformity of material and because of the difficulties of marking. Having experienced the practical problems involved in running a scheme for 42 laboratories, we believe that the best solution would be to organise a network of regional schemes, and involve participating laboratories in assessment. This not only reduces the understandable concern about central control, but also increases the feeling of involvement, and broadens the experience of the staff concerned. It also means that a central laboratory is not required, and the additional work load for the department asked to run the regional scheme is not great. The most important need would be for a part time confidential secretary in each of the centres.
We have shown in this pilot scheme that assessment of technical quality of histopathology sections can be made sufficiently accurate and reproducible for use in an EQA scheme in histopathology. We have shown that such a scheme can be organised efficiently for a group of about 40 laboratories, and that it is in general endorsed by the participating laboratories. At the start of this discussion we commented that the main criticisms of EQA schemes in histopathology were that they were unnecessary, unworkable, and inaccurate. We have now shown that they can be made workable and accurate. There is no doubt that they can be acceptable, and we believe they are necessary.
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